feed,title,long_url,short_url
SeekingAlpha,"John Hancock Preferred CEFs Relatively Cheap, For A Reason?",https://seekingalpha.com/article/4393030,
SeekingAlpha,PDL BioPharma Liquidation May Offer 40% Upside For Patient Investors Comfortable With Illiquidity,https://seekingalpha.com/article/4393029,
